CD19 and myelodysplastic syndrome: As shown in Figure 1 and Table 5, the patients with high-grade MDS showed higher percentages of CD34+ blasts, lower CD19 and CD38 expression, and higher CD117 expression on CD34+ blasts compared with the patients with non-clonal cytopenia (all P<0.05).